Medical Properties Trust (MPW) Expected to Post Quarterly Sales of $204.76 Million

Brokerages forecast that Medical Properties Trust (NYSE:MPW) will post $204.76 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Medical Properties Trust’s earnings, with the lowest sales estimate coming in at $195.35 million and the highest estimate coming in at $208.42 million. Medical Properties Trust posted sales of $156.40 million in the same quarter last year, which suggests a positive year over year growth rate of 30.9%. The business is scheduled to issue its next earnings report on Thursday, May 3rd.

On average, analysts expect that Medical Properties Trust will report full-year sales of $204.76 million for the current year, with estimates ranging from $787.64 million to $833.42 million. For the next year, analysts forecast that the business will report sales of $838.74 million per share, with estimates ranging from $812.21 million to $859.75 million. Zacks’ sales calculations are an average based on a survey of analysts that cover Medical Properties Trust.

How to Become a New Pot Stock Millionaire

Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings data on Thursday, February 8th. The real estate investment trust reported $0.37 EPS for the quarter, topping the Zacks’ consensus estimate of $0.35 by $0.02. The company had revenue of $205.00 million for the quarter, compared to analyst estimates of $204.52 million. Medical Properties Trust had a return on equity of 7.85% and a net margin of 41.12%. The firm’s quarterly revenue was up 33.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.31 earnings per share.

A number of equities analysts recently commented on the company. ValuEngine lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Monday, April 2nd. Deutsche Bank lowered their target price on Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating for the company in a report on Monday, March 19th. Zacks Investment Research upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. JPMorgan Chase upgraded Medical Properties Trust from an “underweight” rating to a “neutral” rating and set a $14.50 target price for the company in a report on Friday, December 15th. Finally, Robert W. Baird downgraded Medical Properties Trust from an “outperform” rating to a “neutral” rating and lowered their target price for the stock from $15.00 to $13.00 in a report on Friday, January 5th. Eight research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $14.28.

Medical Properties Trust stock opened at $12.69 on Friday. The company has a current ratio of 2.06, a quick ratio of 2.06 and a debt-to-equity ratio of 1.28. The company has a market capitalization of $4,682.68, a P/E ratio of 9.40, a P/E/G ratio of 2.55 and a beta of 0.69. Medical Properties Trust has a one year low of $11.82 and a one year high of $14.22.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 12th. Shareholders of record on Thursday, March 15th will be issued a $0.25 dividend. This is an increase from Medical Properties Trust’s previous quarterly dividend of $0.24. This represents a $1.00 dividend on an annualized basis and a yield of 7.88%. The ex-dividend date of this dividend is Wednesday, March 14th. Medical Properties Trust’s payout ratio is presently 74.07%.

In other news, Chairman Edward K. Aldag, Jr. sold 116,216 shares of the business’s stock in a transaction that occurred on Tuesday, March 27th. The stock was sold at an average price of $12.56, for a total transaction of $1,459,672.96. Following the completion of the sale, the chairman now owns 1,759,620 shares in the company, valued at $22,100,827.20. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Chairman Edward K. Aldag, Jr. sold 489,971 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The shares were sold at an average price of $12.39, for a total value of $6,070,740.69. Following the sale, the chairman now owns 2,192,629 shares of the company’s stock, valued at approximately $27,166,673.31. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MPW. Ameriprise Financial Inc. increased its holdings in shares of Medical Properties Trust by 2.3% during the third quarter. Ameriprise Financial Inc. now owns 1,441,628 shares of the real estate investment trust’s stock valued at $18,931,000 after acquiring an additional 32,563 shares in the last quarter. Great West Life Assurance Co. Can increased its holdings in shares of Medical Properties Trust by 2.9% during the third quarter. Great West Life Assurance Co. Can now owns 253,247 shares of the real estate investment trust’s stock valued at $3,290,000 after acquiring an additional 7,073 shares in the last quarter. Legal & General Group Plc increased its holdings in shares of Medical Properties Trust by 11.8% during the third quarter. Legal & General Group Plc now owns 1,234,155 shares of the real estate investment trust’s stock valued at $16,205,000 after acquiring an additional 130,328 shares in the last quarter. Virginia Retirement Systems ET AL bought a new stake in shares of Medical Properties Trust during the third quarter valued at approximately $386,000. Finally, JPMorgan Chase & Co. increased its holdings in shares of Medical Properties Trust by 157.1% during the third quarter. JPMorgan Chase & Co. now owns 641,841 shares of the real estate investment trust’s stock valued at $8,338,000 after acquiring an additional 392,227 shares in the last quarter. Hedge funds and other institutional investors own 80.89% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.tickerreport.com/banking-finance/3339998/medical-properties-trust-mpw-expected-to-post-quarterly-sales-of-204-76-million.html.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

National Grid  Given a GBX 780 Price Target at Deutsche Bank
National Grid Given a GBX 780 Price Target at Deutsche Bank
Rolls-Royce  Earns Conviction-Buy Rating from Goldman Sachs
Rolls-Royce Earns Conviction-Buy Rating from Goldman Sachs
Relx  Given “Buy” Rating at Deutsche Bank
Relx Given “Buy” Rating at Deutsche Bank
Tesco’s  “Buy” Rating Reiterated at Goldman Sachs
Tesco’s “Buy” Rating Reiterated at Goldman Sachs
Halcon Resources Co.  Expected to Post Q1 2019 Earnings of $0.07 Per Share
Halcon Resources Co. Expected to Post Q1 2019 Earnings of $0.07 Per Share
Signet Jewelers Forecasted to Earn Q1 2019 Earnings of  Per Share
Signet Jewelers Forecasted to Earn Q1 2019 Earnings of Per Share


Leave a Reply

© 2006-2018 Ticker Report. Google+.